199682-73-0

Basic information

• Product Name: 3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE
• Synonyms: 3-(4-methoxyphenyl)-1H-pyrazole-4-carbaldehyde(SALTDATA: FREE);3-(4-Methoxyphenyl)-1H-pyrazole-4-carboxaldehyde, 97%;TIMTEC-BB SBB006793;AKOS B000244;3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE;3-(4-METHOXYPHENYL)PYRAZOLE-4-CARBOXALDEHYDE;ART-CHEM-BB B000244
• CAS NO: 199682-73-0
• Molecular Formula: C₁₁H₁₀N₂O₂
• Molecular Weight: 202.21
• EINECS: 633-748-7
• Mol File: 199682-73-0.mol

Chemical Properties

• Melting Point: 160 °C
• Boiling Point: 449.2°C at 760 mmHg
• Flash Point: 225.5°C
• Appearance: /
• Density: 1.248g/cm³
• Vapor Pressure: 2.91E-08mmHg at 25°C
• Refractive Index: 1.618
• Sensitive: Air Sensitive
• CAS DataBase Reference: 3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE(199682-73-0)
• EPA Substance Registry System: 3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE(199682-73-0)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• Safety Statements: S24/25:Avoid contact with skin and eyes.
• HazardClass: IRRITANT
• Hazardous Substances Data: 199682-73-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
3-(4-Methoxyphenyl)-1H-pyrazole-4-carbaldehyde is utilized as an intermediate in organic synthesis processes, contributing to the formation of complex organic molecules with diverse applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-(4-Methoxyphenyl)-1H-pyrazole-4-carbaldehyde serves as a building block for the development of novel bioactive compounds. Its incorporation into pharmaceuticals and agrochemicals is facilitated by its unique chemical structure, which can be further modified to enhance its properties and effectiveness.
Used in Pharmaceutical Industry:
3-(4-Methoxyphenyl)-1H-pyrazole-4-carbaldehyde is used as a key intermediate for the synthesis of pharmaceuticals, where it may contribute to the development of new drugs with improved therapeutic profiles.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE is employed as an intermediate in the synthesis of agrochemicals, potentially leading to the creation of new pesticides or other agricultural chemicals that can address specific needs in crop protection and management.
The specific applications and properties of 3-(4-Methoxyphenyl)-1H-pyrazole-4-carbaldehyde are subject to ongoing research and development, which will determine its full potential in various industries.

InChI:InChI=1/C11H10N2O2/c1-15-10-4-2-8(3-5-10)11-9(7-14)6-12-13-11/h2-7H,1H3,(H,12,13)

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 717-14-6 4-methoxyacetophenone semicarbazone 
• 120445-97-8 C₁₀H₁₃N₃O₂ 
• 100-06-1 1-(4-methoxyphenyl)ethanone 

Downstream Products

• 1071813-39-2 C₁₇H₁₃N₅O₂S₂ 
• 1187037-67-7 C₁₄H₁₄N₆OS 
• 1187037-75-7 C₁₆H₁₈N₆OS 
• 1187037-84-8 C₁₉H₁₆N₆OS 
• 1346239-60-8 diethyl 4-[3-(4-methoxyphenyl)-1H-pyrazol-4-yl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
• 1346239-72-2 dimethyl 4-[3-(4-methoxyphenyl)-1H-pyrazol-4-yl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
• 1347062-97-8 3-ethyl-6-(3-(4-methoxyphenyl)-1H-pyrazol-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole 
• 1347063-09-5 3-propyl-6-(3-(4-methoxyphenyl)-1H-pyrazol-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole 
• 1378893-78-7 C₂₀H₁₈N₆O₂S 
• 1378893-39-0 3-(3-mercapto-5-(phenoxymethyl)-4H-1,2,4-triazol-4-yl)-2-(3-(4-methoxyphenyl)-1H-pyrazol-4-yl)thiazolidin-4-one 
• 1378893-82-3 C₂₁H₂₀N₆O₂S 
• 1378893-46-9 3-(3-mercapto-5-(o-tolyloxymethyl)-4H-1,2,4-triazol-4-yl)-2-(3-(4-methoxyphenyl)-1H-pyrazol-4-yl)thiazolidin-4-one 
• 1378893-86-7 C₂₁H₂₀N₆O₂S 
• 1378893-61-8 3-(3-mercapto-5-((naphthalen-1-yloxy)methyl)-4H-1,2,4-triazol-4-yl)-2-(3-(4-methoxyphenyl)-1H-pyrazol-4-yl)thiazolidin-4-one 

Relevant articles and documents

Design and synthesis of amino acid derivatives of substituted benzimidazoles and pyrazoles as Sirt1 inhibitors

Owing to its presence in several biological processes, Sirt1 acts as a potential therapeutic target for many diseases. Here, we report the structure-based designing and synthesis of two distinct series of novel Sirt1 inhibitors, benzimidazole mono-peptide

Synthesis and evaluation of antimicrobial and anticancer activities of 3-phenyl-1-phenylsulfonyl pyrazoles containing an aminoguanidine moiety

A series of 3-phenyl-1-phenylsulfonyl pyrazoles containing an aminoguanidine moiety was designed, synthesized, and evaluated for their antimicrobial and anticancer activities. The majority of the target compounds showed broad-spectrum antimicrobial activi

Synthesis and biological evaluation of some pyrazole derivatives, containing (Thio) semicarbazide, as dual anti-inflammatory antimicrobial agents

Background: Several series of pyrazole derivatives containing (thio) semicarbazide (4a-4h, 5a-5l, 6a-6f, 7a-7c) were designed and synthesized to screen dual inflammatory and antimicrobial activities. Methods: The products were characterized by1

Synthesis and antimicrobial evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives

Background: An alarming increment in pathogenic resistance to existing anti-microbial agents is a serious problem and the treatment of these bacterial infections is becoming increasingly challenging. Therefore, there is an urgent need to develop novel ant

Synthesis and antitubercular and antibacterial activity of some active fluorine containing quinoline–pyrazole hybrid derivatives

In an attempt to develop newer antitubercular and antibacterial agents against the increasing bacterial resistance, we have designed new quinoline–pyrazole analogs (8a–u) following the molecular hybridization approach. The structure of one of the final compounds, 8a was unambiguously confirmed by single crystal X-ray diffraction (SC-XRD) analysis. The target compounds were evaluated for their antitubercular activity against Mycobacterium tuberculosis and antibacterial activity against three common pathogenic bacterial strains. Four derivatives (8b, 8c, 8j and 8o) displayed significant antitubercular activity. The compounds derived from 8-trifluoromethylquinoline and 6-fluoroquinoline scaffolds with halogen substitution on the pyrazole ring exhibited superior inhibition activity than corresponding 6-methoxyquinoline analogs. The cytotoxic studies revealed that the active compounds are nontoxic to normal Vero cell lines with selectivity index values ≥10, which indicate the suitability of these compounds for further drug development. The in silico molecular docking study demonstrated strong binding affinity of the compounds with the target enzymes (InhA, CYP121 and TMPK) of M. tuberculosis. Further, the in vitro antibacterial activity of compounds 8b, 8c, 8d and 8g is comparable with that of the reference drug, Ciprofloxacin.

Hantzsch reaction: Synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents

In the present study two new series of Hantzsch 1,4-dihydropyridine derivatives (1,4-DHPs) containing substituted pyrazole moiety (4a-f and 5a-f) were synthesized by the reaction of 3-aryl-1H-pyrazole-4-carbaldehydes with 1,3-dicarbonylcompounds (ethylace

Structure-activity relationship study of a novel necroptosis inhibitor, necrostatin-7

Necroptosis is a regulated caspase-independent cell death mechanism characterized by morphological features resembling non-regulated necrosis. Necrotatin-7 (Nec-7), a novel potent small-molecule inhibitor of necroptosis, is structurally distinct from previously described necrostatins (Nec-1, Nec-3, Nec-4 and Nec-5). Here, we describe a series of structural modifications and the structure-activity relationship (SAR) of the Nec-7 series for inhibiting necroptosis.

Synthesis of 3-substituted arylpyrazole-4-carboxylic acids

A method was suggested for preparing previously unknown 3-aryl-substituted pyrazole-4-carboxylic acids, involving Vilsmeier formylation of semicarbazones of 26 available mono- and disubstituted acetophenones and 2-acetylthiophene followed by oxidation of

A new synthethic approach to indazole synthesis

Stobbe condensation of 3-alkyl- or aryl-4-formylpyrazoles 3a-f with diethyl succinate in the presence of potassium f-butoxide, followed by intramolecular ring closure (Ac2O-NaOAc), afforded the corresponding indazole derivatives 5a-f in 65-85% overall yield. These compounds are good starting materials for transformation to biologically active molecules, such as new pyrazole analogs of the left-hand segment of the potent natural antineoplastic agent CC-1065.